Sign up for free insights newsletter
AJ

DocCheck AG

AJ91XETRA (Frankfurt)

Need professional-grade analysis? Visit stockanalysis.com

€12.40
-1.59%
End of day
Market Cap

$63.93M

P/E Ratio

10.96

Employees

383

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino10.07-0.13-0.142.23-0.301.52
Calmar29.59-0.15-0.151.94-0.113.54
Sharpe7.034.50-0.08-0.091.32-0.191.05
Omega1.931.021.011.290.991.18
Martin65.22-0.33-0.365.28-0.148.09
Ulcer0.003.139.428.637.5656.0019.34

DocCheck AG (AJ91) Price Performance

DocCheck AG (AJ91) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at EUR12.40, down 1.59% from the previous close.

Over the past year, AJ91 has traded between a low of EUR9.01 and a high of EUR13.60. The stock has gained 37.7% over this period. It is currently 8.8% below its 52-week high.

DocCheck AG has a market capitalization of $63.93M, with a price-to-earnings ratio of 10.96.

About DocCheck AG

DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.

Compare DocCheck AG

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
XETRA (Frankfurt)
Currency
EUR
Country
Germany

Financial Metrics

Revenue (TTM)
$56.60M
EBITDA
$10.78M
Profit Margin
9.42%
EPS (TTM)
1.15
Book Value
8.20

Technical Indicators

52 Week High
€13.80
52 Week Low
€8.58
50 Day MA
€12.26
200 Day MA
€12.30
Beta
0.82

Valuation

Trailing P/E
10.96
Forward P/E
N/A
Price/Sales
1.13
Price/Book
1.65
Enterprise Value
$47.95M